Myelodysplastic Syndrome
Antithymocyte globulin-based therapy shows promise for MDS treatment
Published in Blood Weekly, December 11th, 2003
Scientists in the United States conducted a study "to determine the efficacy of and tolerance to antithymocyte globulin (ATG)-based therapy" in MDS patients.
"Therapy consisted of ATG 40 mg/kg/day daily intravenously (i.v.) for four days; cyclosporine daily orally for 6 months with levels titrated between 200 and 400 mg/dL; and methylprednisone 1 mg/kg i.v. daily before each dose of ATG," explained S. Yazji and coauthors at the University of Texas' M.D. Anderson Cancer Center.
"Of 32 patients treated, 31 patients were evaluable. The median age...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-12-11)
More Articles from Blood Weekly
- Stem-Cell Research
Endoglin-based method enables purification of long-term repopulating HSCs - Leukemia Therapy
In AML patients, pretransplant MRD status predicts auto-SCT outcome - Leukemia Therapy
Stem cell mobilization feasible with rHu-G-CSF alone for CML patients in IM-induced CCR - Stem-Cell Research
IL-7 receptor expression determines lymphoid cell fate - Stem-Cell Transplantation
Low-dose cidofovir effective against post-SCT adenovirus infection - AIDS Epidemiology
China's AIDS epidemic is reaching "frightening" levels, renowned expert says - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
